Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2019 June;110(3) > Minerva Medica 2019 June;110(3):273-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2019 June;110(3):273-5

DOI: 10.23736/S0026-4806.19.05979-2

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC

Biyuan ZHANG 1, Haiji WANG 1 ✉, Qi WANG 1, Jinpeng XU 1, Peng JIANG 2, Wei LI 2

1 Department of Radiation Oncology, Affiliated Hospital of Qingdao University, Qingdao, China; 2 Center of Radiotherapy Technology, Affiliated Hospital of Qingdao University, Qingdao, China


HTML PDF


top of page

 

Copyright © 2021 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions